StockData
CV Sciences, Inc. logo

CV Sciences, Inc. (CVSI) stock

CVSIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$0.01−0.00 (-21.13%)

Close on Oct 19, 2026Market cap $2.53MP/E –Yield –

CV Sciences ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

CV Sciences's ebitda for the twelve months ending Sep 30, 2026 was -$228.00K. For fiscal 2025 it was -$278.00K. The highest annual figure on record is $10.77M in fiscal 2018.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$278.00K–
FY2024Dec 31, 2024-$1.86M-151.6%
FY2023Dec 31, 2023$3.60M–
FY2022Dec 31, 2022-$5.86M–
FY2021Dec 31, 2021-$17.29M–
FY2020Dec 31, 2020-$21.72M–
FY2019Dec 31, 2019-$16.52M-253.5%
FY2018Dec 31, 2018$10.77M–
FY2017Dec 31, 2017-$4.68M–
FY2016Dec 31, 2016-$12.02M–
FY2015Dec 31, 2015-$10.20M–
FY2014Dec 31, 2014-$7.62M–
FY2013Dec 31, 2013-$850.08K–
FY2012Dec 31, 2012-$43.02K–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$400.00K–
Q2 FY2026Jun 30, 2026-$279.00K–
Q1 FY2026Mar 31, 2026-$295.00K-417.2%
Q4 FY2025Dec 31, 2025-$54.00K–
Q3 FY2025Sep 30, 2025-$244.00K–
Q2 FY2025Jun 30, 2025-$73.00K–
Q1 FY2025Mar 31, 2025$93.00K–
Q4 FY2024Dec 31, 2024-$532.00K–
Q3 FY2024Sep 30, 2024-$260.00K–
Q2 FY2024Jun 30, 2024-$507.00K–
Q1 FY2024Mar 31, 2024-$557.00K-109.6%
Q4 FY2023Dec 31, 2023-$830.00K–
Q3 FY2023Sep 30, 2023-$379.00K–
Q2 FY2023Jun 30, 2023-$1.02M–
Q1 FY2023Mar 31, 2023$5.82M–
Q4 FY2022Dec 31, 2022-$2.06M–
Q3 FY2022Sep 30, 2022-$829.00K–
Q2 FY2022Jun 30, 2022-$1.97M–
Q1 FY2022Mar 31, 2022-$998.00K–
Q4 FY2021Dec 31, 2021-$8.44M–
Q3 FY2021Sep 30, 2021-$2.64M–
Q2 FY2021Jun 30, 2021-$3.31M–
Q1 FY2021Mar 31, 2021-$2.91M–
Q4 FY2020Dec 31, 2020-$9.22M–
Q3 FY2020Sep 30, 2020-$2.91M–
Q2 FY2020Jun 30, 2020-$4.45M-411.2%
Q1 FY2020Mar 31, 2020-$5.14M–
Q4 FY2019Dec 31, 2019-$7.16M-346.9%
Q3 FY2019Sep 30, 2019-$1.59M-143.6%
Q2 FY2019Jun 30, 2019$1.43M-58.2%
Q1 FY2019Mar 31, 2019-$9.20M-1269.1%
Q4 FY2018Dec 31, 2018$2.90M+1566.8%
Q3 FY2018Sep 30, 2018$3.66M–
Q2 FY2018Jun 30, 2018$3.42M–
Q1 FY2018Mar 31, 2018$787.00K–
Q4 FY2017Dec 31, 2017$173.98K–
Q3 FY2017Sep 30, 2017-$442.03K–
Q2 FY2017Jun 30, 2017-$811.50K–
Q1 FY2017Mar 31, 2017-$3.60M–
Q4 FY2016Dec 31, 2016-$7.96M–

More CV Sciences figures

See a number that looks wrong?